Recent Updates
Recently added Catalysts
CTNM Positive Sentiment

Contineum Therapeutics to Present at the Stifel 2026 Healthcare Conference

Thursday, October 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Contineum Therapeutics, Inc. will present at the Stifel 2026 Healthcare Conference on November 12th at 8:40 a.m. ET. The company focuses on developing small molecule therapies for inflammatory and fibrotic diseases. An audio webcast of the presentation will be available on their Investors section.

Market Sentiment Analysis

POSITIVE FACTORS

  • Management scheduled to present at a major healthcare conference.
  • Focus on innovative therapies for inflammatory and fibrotic diseases.
  • Opportunity to engage with investors and stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
2.8%
average across 4 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
PIPE-307
Phase 2 · Relapsing Remitting Multiple Sclerosis

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that management is scheduled to present at the Stifel 2026 Healthcare Conference on Thursday, November 12th at 8:40 a.m. ET. An audio webcast of the fireside chat can be accessed on the Investors section of Contineum’s we

Frequently Asked Questions

When will Contineum present at the conference?

Contineum will present on November 12th at 8:40 a.m. ET.

Where can I access the presentation?

The audio webcast will be available on the Investors section of Contineum's website.

What is the focus of Contineum Therapeutics?

The company develops small molecule therapies for inflammatory and fibrotic diseases.

What type of event is the Stifel 2026 Healthcare Conference?

It is a major healthcare conference where companies present their innovations.

ShareAdd on Google
Tags: CTNM Contineum Therapeutics Stifel Conference healthcare biopharmaceuticals
Last updated: Oct 29, 2026

Biotech snapshot

Cash runway
$237M liquidity · $4M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PIPE-307Phase 2
Relapsing Remitting Multiple Sclerosis →

Catalyst track record

+63%
best trade around CTNM's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for CTNM.

See every catalyst's timing & PoA →